← Braidwell portfolio
13F-HR filing
VALIDATEDHoldings period 2024-06-30 · Filed 2024-08-14 · Accession 0001420506-24-001566
Open official SEC source ↗| # | Issuer | Class / CUSIP | Kind | Shares | Value |
|---|---|---|---|---|---|
| 1 | 4D MOLECULAR THERAPEUTICS IN | COM · 35104E100 | LONG | 369,458 | $7.8 million |
| 2 | 89BIO INC | COM · 282559103 | LONG | 164,227 | $1.3 million |
| 3 | AKERO THERAPEUTICS INC | COM · 00973Y108 | LONG | 1,084,400 | $25.4 million |
| 4 | ALECTOR INC | COM · 014442107 | LONG | 2,380,704 | $10.8 million |
| 5 | ALIGN TECHNOLOGY INC | COM · 016255101 | LONG | 275,207 | $66.4 million |
| 6 | ALPHATEC HLDGS INC | COM NEW · 02081G201 | LONG | 2,194,900 | $22.9 million |
| 7 | ALPHATEC HLDGS INC | NOTE 0.750% 8/0 · 02081GAB8 | LONG | 58,217,000 | $56.6 million |
| 8 | APELLIS PHARMACEUTICALS INC | COM · 03753U106 | LONG | 611,800 | $23.5 million |
| 9 | APOGEE THERAPEUTICS INC | COM · 03770N101 | LONG | 2,392,042 | $94.1 million |
| 10 | ARGENX SE | SPONSORED ADR · 04016X101 | LONG | 166,924 | $71.8 million |
| 11 | ARVINAS INC | COM · 04335A105 | LONG | 517,230 | $13.8 million |
| 12 | AVADEL PHARMACEUTICALS PLC | COM SHS · G29687103 | LONG | 2,898,639 | $40.8 million |
| 13 | BRIDGEBIO PHARMA INC | COM · 10806X102 | LONG | 345,571 | $8.8 million |
| 14 | BRIDGEBIO PHARMA INC | NOTE 2.250% 2/0 · 10806XAD4 | LONG | 65,594,000 | $52.3 million |
| 15 | BRIDGEBIO PHARMA INC | NOTE 2.500% 3/1 · 10806XAB8 | LONG | 140,838,000 | $143.0 million |
| 16 | CASTLE BIOSCIENCES INC | COM · 14843C105 | LONG | 416,100 | $9.1 million |
| 17 | CELCUITY INC | COM · 15102K100 | LONG | 516,643 | $8.5 million |
| 18 | CG ONCOLOGY INC | COM · 156944100 | LONG | 3,309,507 | $104.5 million |
| 19 | CONMED CORP | NOTE 2.250% 6/1 · 207410AH4 | LONG | 5,000,000 | $4.5 million |
| 20 | CULLINAN THERAPEUTICS INC | COM · 230031106 | LONG | 176,173 | $3.1 million |
| 21 | CUTERA INC | NOTE 4.000% 6/0 · 232109AG3 | LONG | 29,000,000 | $5.0 million |
| 22 | CUTERA INC | NOTE 2.250% 6/0 · 232109AD0 | LONG | 25,240,000 | $5.0 million |
| 23 | DAY ONE BIOPHARMACEUTICALS I | COM · 23954D109 | LONG | 3,035,904 | $41.8 million |
| 24 | DBV TECHNOLOGIES S A | SPONSORED ADR · 23306J200 | LONG | 2,442,504 | $2.0 million |
| 25 | DEXCOM INC | NOTE 0.375% 5/1 · 252131AM9 | LONG | 82,700,000 | $81.2 million |
| 26 | DEXCOM INC | NOTE 0.250%11/1 · 252131AK3 | LONG | 73,500,000 | $73.8 million |
| 27 | DIANTHUS THERAPEUTICS INC | COM · 252828108 | LONG | 366,851 | $9.5 million |
| 28 | ELEVATION ONCOLOGY INC | COM · 28623U101 | LONG | 2,477,614 | $6.7 million |
| 29 | EXACT SCIENCES CORP | COM · 30063P105 | LONG | 1,141,678 | $48.2 million |
| 30 | GLAUKOS CORP | COM · 377322102 | LONG | 496,576 | $58.8 million |
| 31 | GUARDANT HEALTH INC | COM · 40131M109 | LONG | 2,807,968 | $81.1 million |
| 32 | GUARDANT HEALTH INC | NOTE11/1 · 40131MAB5 | LONG | 268,252,000 | $208.1 million |
| 33 | HAEMONETICS CORP MASS | NOTE3/0 · 405024AB6 | LONG | 11,500,000 | $10.4 million |
| 34 | HARROW INC | COM · 415858109 | LONG | 297,188 | $6.2 million |
| 35 | IMMUNOCORE HLDGS PLC | ADS · 45258D105 | LONG | 797,268 | $27.0 million |
| 36 | INSPIRE MED SYS INC | COM · 457730109 | LONG | 379,443 | $50.8 million |
| 37 | INSULET CORP | NOTE 0.375% 9/0 · 45784PAK7 | LONG | 68,000,000 | $74.4 million |
| 38 | INTUITIVE SURGICAL INC | COM NEW · 46120E602 | LONG | 100,500 | $44.7 million |
| 39 | IOVANCE BIOTHERAPEUTICS INC | COM · 462260100 | LONG | 1,466,610 | $11.8 million |
| 40 | IRHYTHM HOLDINGS INC | COM · 450056106 | LONG | 526,357 | $56.7 million |
| 41 | IRONWOOD PHARMACEUTICALS INC | COM CL A · 46333X108 | LONG | 4,438,232 | $28.9 million |
| 42 | IRONWOOD PHARMACEUTICALS INC | NOTE 1.500% 6/1 · 46333XAH1 | LONG | 89,740,000 | $84.6 million |
| 43 | KEROS THERAPEUTICS INC | COM · 492327101 | LONG | 982,209 | $44.9 million |
| 44 | KINIKSA PHARMACEUTICALS INTL | ORD SHS CL A · G52694109 | LONG | 2,058,303 | $38.4 million |
| 45 | KRYSTAL BIOTECH INC | COM · 501147102 | LONG | 107,179 | $19.7 million |
| 46 | LEGEND BIOTECH CORP | SPONSORED ADS · 52490G102 | LONG | 1,669,720 | $74.0 million |
| 47 | LEXEO THERAPEUTICS INC | COM · 52886X107 | LONG | 1,382,481 | $22.2 million |
| 48 | LEXICON PHARMACEUTICALS INC | COM NEW · 528872302 | LONG | 8,294,950 | $13.9 million |
| 49 | LIVANOVA PLC | SHS · G5509L101 | LONG | 173,900 | $9.5 million |
| 50 | LONGBOARD PHARMACEUTICALS IN | COM · 54300N103 | LONG | 205,926 | $5.6 million |
| 51 | MARAVAI LIFESCIENCES HLDGS I | COM CL A · 56600D107 | LONG | 9,024,037 | $64.6 million |
| 52 | NEOGENOMICS INC | NOTE 0.250% 1/1 · 64049MAB6 | LONG | 116,381,000 | $90.8 million |
| 53 | NEUROCRINE BIOSCIENCES INC | COM · 64125C109 | LONG | 759,009 | $104.5 million |
| 54 | NEVRO CORP | COM · 64157F103 | LONG | 1,698,768 | $14.3 million |
| 55 | NOVOCURE LTD | NOTE11/0 · 67011XAB9 | LONG | 140,834,000 | $129.8 million |
| 56 | NUVASIVE INC | NOTE 0.375% 3/1 · 670704AJ4 | LONG | 114,206,000 | $110.1 million |
| 57 | OCULAR THERAPEUTIX INC | COM · 67576A100 | LONG | 1,643,770 | $11.2 million |
| 58 | ORTHOPEDIATRICS CORP | COM · 68752L100 | LONG | 1,107,770 | $31.9 million |
| 59 | OUTSET MED INC | COM · 690145107 | LONG | 694,525 | $2.7 million |
| 60 | PARAGON 28 INC | COM · 69913P105 | LONG | 4,150,109 | $28.4 million |
| 61 | PENUMBRA INC | COM · 70975L107 | LONG | 212,594 | $38.3 million |
| 62 | PULMONX CORP | COM · 745848101 | LONG | 752,541 | $4.8 million |
| 63 | RELAY THERAPEUTICS INC | COM · 75943R102 | LONG | 3,006,799 | $19.6 million |
| 64 | REPLIGEN CORP | COM · 759916109 | LONG | 323,509 | $40.8 million |
| 65 | REPLIMUNE GROUP INC | COM · 76029N106 | LONG | 1,013,377 | $9.1 million |
| 66 | SAREPTA THERAPEUTICS INC | COM · 803607100 | LONG | 81,900 | $12.9 million |
| 67 | SAREPTA THERAPEUTICS INC | NOTE 1.250% 9/1 · 803607AD2 | LONG | 43,066,000 | $55.5 million |
| 68 | SPYRE THERAPEUTICS INC | COM NEW · 00773J202 | LONG | 2,514,538 | $59.1 million |
| 69 | THE BEAUTY HEALTH COMPANY | COM CL A · 88331L108 | LONG | 5,120,685 | $9.8 million |
| 70 | THERMO FISHER SCIENTIFIC INC | COM · 883556102 | LONG | 70,449 | $39.0 million |
| 71 | TRANSMEDICS GROUP INC | COM · 89377M109 | LONG | 189,960 | $28.6 million |
| 72 | TRAVERE THERAPEUTICS INC | NOTE 2.500% 9/1 · 761299AB2 | LONG | 56,031,000 | $48.8 million |
| 73 | VAXCYTE INC | COM · 92243G108 | LONG | 808,303 | $61.0 million |
| 74 | VIKING THERAPEUTICS INC | COM · 92686J106 | LONG | 1,106,905 | $58.7 million |
| 75 | XENON PHARMACEUTICALS INC | COM · 98420N105 | LONG | 2,560,573 | $99.8 million |